Paper Details
- Home
- Paper Details
Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).
Author: HirasawaYoko, HiyoshiToru, InabaNaoyuki, IshiiHitoshi, KandaEiichiro, KurodaHisamoto, MohriTakako, NakajimaHiroki, NiiyaTetsuji, OkadaSadanori, SeinoHiroaki
Original Abstract of the Article :
The benefits of sodium glucose cotransporters 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus include plasma glucose control, reduction in body weight and blood pressure, and low risk of hypoglycemia, although they may also cause genitourinary infections, polyuria, or volume depletion...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831584/
データ提供：米国国立医学図書館（NLM）
Dapagliflozin Improves Treatment Satisfaction in Overweight Patients with Type 2 Diabetes Mellitus
In the vast desert of diabetes management, finding effective and well-tolerated treatments is a constant challenge. This study, like a camel caravan seeking a safe and comfortable path through the desert, explores the impact of dapagliflozin, a medication for type 2 diabetes, on treatment satisfaction in overweight individuals. The authors investigated the effects of dapagliflozin on blood sugar control, weight loss, and overall treatment satisfaction, aiming to provide a more comprehensive understanding of its benefits.
Dapagliflozin: A Promising Treatment Option for Diabetes
The study demonstrated that dapagliflozin significantly improved treatment satisfaction in overweight patients with type 2 diabetes, despite the potential for side effects. This finding, like a cool oasis in the desert, offers a promising treatment option that addresses both physical and psychological well-being. The study highlights the importance of considering patients' overall experience and satisfaction when evaluating treatment options.
Diabetes Management: A Journey of Well-being
This study underscores the importance of considering patient-reported outcomes when evaluating diabetes treatments. Effective management of diabetes requires a comprehensive approach that addresses not only blood sugar control but also overall well-being. Just as a camel caravan needs a well-stocked oasis for rest and rejuvenation, individuals with diabetes need treatment options that support their physical and emotional health.
Dr.Camel's Conclusion
This study highlights the potential of dapagliflozin to improve treatment satisfaction in overweight patients with type 2 diabetes. The findings underscore the importance of considering patient-reported outcomes and the need for treatment options that address both physical and psychological well-being. The study, like a well-prepared camel caravan, reminds us that the journey of diabetes management requires a comprehensive and patient-centered approach.
Date :
- Date Completed n.d.
- Date Revised 2022-03-16
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.